Lung Cancer Clinical Trial

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

Summary

Our long-term goal is to integrate non-small cell lung cancer patient treatment preferences into clinical treatment planning.

View Full Description

Full Description

The following specific aims are proposed:

Aim 1: Determine whether individual patients' preferences, characteristics, and treatment experiences affect the definition of treatment success.

Aim 2: Determine how to best predict real-life patients' treatment choices based on patients' preferences of adverse events.

Aim 3: Determine whether physicians are likely to change their oncologic clinical practice after receiving a detailed communication of their patients' preferences of adverse events.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Willing and able to provide consent
Greater than or equal to 19 years of age
Diagnosed with stage IV non-small cell lung cancer (NSCLC)
Able to understand spoken English

Eligible to undergo chemotherapy for stage IV NSCLC, to include, but not limited to, those who:

have not yet started chemo
are currently undergoing chemo for stage IV NSCLC
have completed first line stage IV NSCLC chemo or progressed to maintenance for stage IV NSCLC within the last 30 days
elect to have chemo elsewhere -- not at one of the study sites
decline chemo

Exclusion Criteria:

Age <19 years
Not willing and/or able to provide consent
Not able to understand spoken English
Not eligible to undergo chemotherapy for stage IV NSCLC

Study is for people with:

Lung Cancer

Estimated Enrollment:

210

Study ID:

NCT02190864

Recruitment Status:

Unknown status

Sponsor:

University of Nebraska

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Moffitt Cancer Center
Tampa Florida, 33612, United States More Info
Jhanelle E Gray, MD
Contact
813-745-6895
[email protected]
Kansas City VA Medical Center
Kansas City Missouri, 64128, United States More Info
Sarah Spancer, RN
Contact
816-861-4700
[email protected]
Saint Francis Cancer Treatment Center
Grand Island Nebraska, 68803, United States
Southeast Nebraska Cancer center
Lincoln Nebraska, 68510, United States More Info
bronson Riley, MS
Contact
402-327-7363
[email protected]
Callahan Cancer Center of Great Plains Regional Medical Center
North Platte Nebraska, 69101, United States More Info
Irfan A Vaziri, MD
Contact
308-696-7864
[email protected]
Nebraska-Western Iowa (NWI) VA Health Care System
Omaha Nebraska, 68105, United States More Info
Joy Egan, RN
Contact
402-995-4143
[email protected]
University of Nebraska Medical Center
Omaha Nebraska, 68198, United States More Info
KM Munirul Islam, MD, PhD
Contact
402-559-8283
[email protected]
Avera Cancer Institute
Sioux Falls South Dakota, 57105, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

210

Study ID:

NCT02190864

Recruitment Status:

Unknown status

Sponsor:


University of Nebraska

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider